Zachary H. Hopkins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zachary H. Hopkins has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
John J. Zone
Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA
7 shared publications- Aaron M. Secrest
Department of Dermatology, University of Utah, Salt Lake City, USA
6 shared publications Zachary Frost
Noorda College of Osteopathic Medicine, Provo, UT, USA
6 shared publicationsAaron M. Secrest
Department of Population Health Sciences, University of Utah Spenser S. Eccles School of Medicine, Salt Lake City, Utah; Department of Dermatology, University of Utah Spenser S. Eccles School of Medicine, Salt Lake City, Utah; Department of Dermatology, Christchurch Hospital, Te Whatu Ora-Waitaha Canterbury, Christchurch, New Zealand
5 shared publicationsChristiaan H. Noot
University of Utah Spencer F. Eccles School of Medicine, Salt Lake City, Utah
5 shared publicationsChristopher M. Hull
Department of Dermatology, University of Utah, Spencer F. Eccles School of Medicine, Autoimmune Skin Diseases Clinic, Salt Lake City, Utah
5 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (5) , 1518-1521
Prevalence and sensitivity of traditional direct immunofluorescent findings in oral and esophageal lichen planus
- 29 July 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (5) , 1518-1521
Open AccessPrevalence and sensitivity of traditional direct immunofluorescent findings in oral and esophageal lichen planus
- Open Access
- 3 June 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 74, 148-151
Successful treatment of refractory cutaneous Crohn’s disease with upadacitinib: A case report
- 3 June 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 74, 148-151
Open AccessSuccessful treatment of refractory cutaneous Crohn’s disease with upadacitinib: A case report
- Open Access
- 1 March 2026
- Published by Edizioni Minerva Medica in Italian Journal of Dermatology and Venereology
The role of antibody class and target on subepidermal blistering disease phenotype and management
Article: The role of antibody class and target on subepidermal blistering disease phenotype and management - Italian Journal of Dermatology and Venereology 2026 Mar 16 - Minerva Medica - Journals
- 1 March 2026
- Published by Edizioni Minerva Medica in Italian Journal of Dermatology and Venereology
Open AccessThe role of antibody class and target on subepidermal blistering disease phenotype and management
Article: The role of antibody class and target on subepidermal blistering disease phenotype and management - Italian Journal of Dermatology and Venereology 2026 Mar 16 - Minerva Medica - Journals
- Open Access
- 4 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 789-791
Ultraviolet A1 phototherapy for improvement of hand function in scleroderma: a blinded prospective study
Effective tools for improving sclerotic hand changes in patients with systemic sclerosis are lacking; thus, we conducted a single-blind prospective randomized clinical trial investigating the impact of UVA1 phototherapy on scleroderma of the hands. Seven patients were unilaterally treated, and we found no evidence of significant change in Hand Mobility in Scleroderma (HAMIS) scores after 30 treatments. However, patients did report significant health-related outcome changes in the emotional, symptomatic and functional domains of Skindex-16 [β = –34.1 (95% CI –47.0 to –21.3), –26.3 (–38.1 to –14.4) and –13.1 (–20.9 to –5.41), respectively].
- 4 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 789-791
Open AccessUltraviolet A1 phototherapy for improvement of hand function in scleroderma: a blinded prospective study
Effective tools for improving sclerotic hand changes in patients with systemic sclerosis are lacking; thus, we conducted a single-blind prospective randomized clinical trial investigating the impact of UVA1 phototherapy on scleroderma of the hands. Seven patients were unilaterally treated, and we found no evidence of significant change in Hand Mobility in Scleroderma (HAMIS) scores after 30 treatments. However, patients did report significant health-related outcome changes in the emotional, symptomatic and functional domains of Skindex-16 [β = –34.1 (95% CI –47.0 to –21.3), –26.3 (–38.1 to –14.4) and –13.1 (–20.9 to –5.41), respectively].
- Open Access
- 24 November 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (3) , 1021-1023
Clinical assessment implications from core outcome domain set development exercises in dermatology
- 24 November 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (3) , 1021-1023
Open AccessClinical assessment implications from core outcome domain set development exercises in dermatology
- Open Access
- 13 October 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (2) , 669-671
The impact of allergen avoidance on oral lichen planus: A retrospective cohort-based comparison
- 13 October 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (2) , 669-671
Open AccessThe impact of allergen avoidance on oral lichen planus: A retrospective cohort-based comparison
- Open Access
- 2 July 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 63, 125-127
Oral lichen planus treated with upadacitinib: a case series
- 2 July 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 63, 125-127
Open AccessOral lichen planus treated with upadacitinib: a case series
- 1 June 2025
- Vol. 18 (6) , 10-13
Physician and Trainee Beliefs and Comfort Regarding Psychodermatology Management: A Cross-sectional Survey From a Large Tertiary Care Center Faculty
Both primary and secondary psychodermatoses are prevalent and dermatologists can play a pivotal role in their managment. We sought to understand dermatologists’ training, comfort, and concerns for prescribing psychotropic medication for these condtions. We surveyed 49 dermatologists at the University of Utah, querying demographic variables, training enviroment, exposure to psychotropic medication use in training, current prescribing comfort, and current prescribing patterns. Associations between questionnaire responses and dermatologist demographics and training patterns were evaluated using ordinal logistic regression. Across the 42 collected surveys, most had limited exposure to psychotropic medication and psychodermtoses managment in residency, most were encouraged to refer these patients to psychiatry, and lack of training on use and side effects were the most commonly cited reasons for not prescribing psychotropic medications. Having more faculty who advocated for psychtropic medication use and training during residency on psychodermatoses were associated with greater prescribing comfort (OR=6.77, 1.54-29.8 and OR=6.09, 1.80–20.6 respectively). Most dermatologists surveyed had limited exposure and training using psychotrophic medications for psychodermatoses. Lack of training and experience with these medications was a significant factor affecting prescribing comfort, highlighting the improtance of expanded residency training on the use of psychotrophic medications and the managent of primary and secondary dermatoses.
- 1 June 2025
- Vol. 18 (6) , 10-13
Physician and Trainee Beliefs and Comfort Regarding Psychodermatology Management: A Cross-sectional Survey From a Large Tertiary Care Center Faculty
Both primary and secondary psychodermatoses are prevalent and dermatologists can play a pivotal role in their managment. We sought to understand dermatologists’ training, comfort, and concerns for prescribing psychotropic medication for these condtions. We surveyed 49 dermatologists at the University of Utah, querying demographic variables, training enviroment, exposure to psychotropic medication use in training, current prescribing comfort, and current prescribing patterns. Associations between questionnaire responses and dermatologist demographics and training patterns were evaluated using ordinal logistic regression. Across the 42 collected surveys, most had limited exposure to psychotropic medication and psychodermtoses managment in residency, most were encouraged to refer these patients to psychiatry, and lack of training on use and side effects were the most commonly cited reasons for not prescribing psychotropic medications. Having more faculty who advocated for psychtropic medication use and training during residency on psychodermatoses were associated with greater prescribing comfort (OR=6.77, 1.54-29.8 and OR=6.09, 1.80–20.6 respectively). Most dermatologists surveyed had limited exposure and training using psychotrophic medications for psychodermatoses. Lack of training and experience with these medications was a significant factor affecting prescribing comfort, highlighting the improtance of expanded residency training on the use of psychotrophic medications and the managent of primary and secondary dermatoses.
- Open Access
- 12 March 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 59, 78-80
Treatment of recalcitrant hypertrophic lichen planus with upadacitinib
- 12 March 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 59, 78-80
Open AccessTreatment of recalcitrant hypertrophic lichen planus with upadacitinib
- 4 March 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 93 (1) , 252-255
Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health
- 4 March 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 93 (1) , 252-255
Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health